Polymorphism in the DNA repair enzyme XRCC1: Utility of current database and implications for human health risk assessment

Mutation Research - Reviews in Mutation Research

Volumn 727, Issue 1-2, 2011, Pages 1-15

  Ginsberg, Gary ^a   Angle, Kenneth ^b   Guyton, Kathryn ^c   Sonawane, Babasaheb ^c  

^a CDC   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

DNA repair; Genetic polymorphism; Risk assessment; Toxicodynamic modeling; XRCC1

Indexed keywords

XRCC1 PROTEIN;

CARCINOGENESIS; CODON; DNA ADDUCT; DNA DAMAGE; DNA POLYMORPHISM; EXCISION REPAIR; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HEALTH HAZARD; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA REPAIR; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 79955098984     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2011.02.001     Document Type: Review

References (105)

1. Al Omari A., Murry D.J. Pharmacogenetics of the cytochrome P450 enzyme system: review of current knowledge and clinical significance. J. Pharm. Practice 2007, 20:206-218.
2. Berlin I., de Brettes B., Aymard G., Diquet B., Arnulf L., Puech A.J. Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor. Int. J. Neuropsychopharmacol. 2000, 3:35-43.
3. Ieiri I., Takane H., Hirota T., Otsubo K., Higuchi S. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy. Expert Opin. Drug Metab. Toxicol. 2006, 2:651-674.
4. Shikata E., Ieiri I., Ishiguro S., Aono H., Inoue K., Koide T., Ohgi S., Otsubo K. Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivity. Blood 2004, 103:2630-2635.
5. He J.Q., Ruan J., Connett J.E., Anthonisen N.R., Paré P.D., Sandford A.J. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am. J. Respir. Crit. Care Med. 2002, 166:323-328.
6. Ross D., Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Meth. Enzymol. Part B 2004, 382:115-143.
7. Andrew A.S., Karagas M.R., Nelson H.H., Guarrera S., Polidoro S., Gamberini S., Sacerdote C., Moore J.H., Kelsey K.T., Demidenko E., Vineis P., Matullo G. DNA repair polymorphisms modify bladder cancer risk: a multifactor analytic strategy. Hum. Hered. 2008, 65:105-118.
8. Shen M.R., Zdzienicka M.Z., Mohrenweiser H., Thompson L.H., Thelen M.P. Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acid Res. 1998, 26(4):1032-1037.
9. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., Cleaver J.E., Pedersen R.A. Requirement for the XRCC1 DNA base excision repair gene during early mouse development. Dev. Biol. 1999, 208:513-529.
10. Li Y., Marion M.J., Zipprich J., Freyer G., Santella R.M., Kanki C., Brandt-Rauf P.W. The role of XRCC1 polymorphisms in base excision repair of etheno-DNA adducts in French vinyl chloride workers. Int. J. Occup. Med. Environ. Health 2006, 19(1):45-52.
11. Caldecott K.W. XRCC1 and DNA strand break repair. DNA Repair 2003, 2:955-969.
12. Horton J.K., Watson M., Stefanick D.F., Shaughnessy D.T., Taylor J.A., Wilson S.H. XRCC1 and DNA polymerase β in cellular protection against cytotoxic DNA single-strand breaks. Cell Res. 2008, 18:48-63.
13. Mortusewicz O., Leonhardt H. XRCC1 and PCNA are loading platforms with distinct kinetic properties and different capacities to respond to multiple DNA lesions. BMC Mol. Biol. 2007, 8:81.
14. Thompson L.H., West M.G. XRCC keeps DNA from getting stranded. Mutat. Res. 2000, 459:1-18.
15. Sterpone S., Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J. Nucleic Acids 2010, Article ID 780369, Available at http://www.sage-hindawi.com/journals/jna/2010/780369.cta.html.
16. Taylor R.M., Thistlethwaite A., Caldecott K.W. Central role for the XRCC1 BRCT 1 domain in mammalian DNA single-strand break repair. Mol. Cell. Biol. 2002, 22(8):2556-2563.
17. Peterman E., Keil C., Oei S.L. Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair 2006, 5:544-555.
18. Parsons J.L., Dianova I.I., Allinson S.L., Dianov G.L. DNA polymerase promotes recruitment of DNA ligase IIIα-XRCC1 to sites of base excision repair. Biochemistry 2005, 44(31):10613-10619.
19. Marintchev A., Mullen M.A., Maciejewski M.W., Pan B., Gryk M.R., Mullen G.P. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat. Struct. Biol. 1999, 6(9):805-806.
20. Mani R.S., Fanta M., Karimi-Busheri F., Silver E., Virgen C.A., Caldecott K.W., Cass C.E., Weinfeld M. XRCC1 stimulates polynucleotide kinase by enhancing its damage discrimination and displacement from DNA repair intermediates. J. Biol. Chem. 2007, 282(38):28004-28013.
21. Thompson L.H., Brookman K.W., Dillehay L.E., Carrano A.V., Mazrimas J.A., Mooney C.L., Minkler J.L. A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister chromatid exchange. Mutat. Res. 1982, 95(2-3):427-440.
22. Thompson L.H., Brookman K.W., Jones N.J., Allen S.A., Carrano A.V. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol. Cell. Biol. 1990, 10(12):6160-6171.
23. Walter C.A., Lu J., Bhakta M., Zhou Z.Q., Thompson L.H., McCarrey J.R. Testis and somatic XRCC-1 DNA repair gene expression. Somat. Cell Mol. Genet. 1994, 20:451-461.
24. Zhou Z.Q., Walter C.A. Expression of the DNA repair gene XRCC1 in baboon tissues. Mutat. Res. 1995, 348:111-116.
25. Yoo H., Li L., Sacks P.G., Thompson L.H., Becker F.F., Chan J.Y. Alterations in expression and structure of the DNA repair gene XRCC1. Biochem. Biophys. Res. Commun. 1992, 186(2):900-910.
26. Hayden P.J., Tewari P., Morris D.W., Staines A., Crowley D., Nieters A., Becker N., de Sanjosé S., Foretova L., Maynadié M., Cocco P.L., Boffetta P., Brennan P., Chanock S.J., Browne P.V., Lawler M. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum. Mol. Genet. 2007, 16(24):3117-3127.
27. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell 1998, 1783-1793.
28. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162(10):925-942.
29. Laczmanska I., Gil J., Karpinski P., Stembalska A., Kozlowska J., Busza H., Trusewicz A., Pesz K., Ramsey D., Schlade-Bartusiak K., Blin N., Sasiadek M.M. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE. Environ. Mol. Mutagen. 2006, 47:666-673.
30. Au W.W., Salama S.A., Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 2003, 111:1843-1850.
31. Lloyd D.R., Hanawalt P.C. p-53 dependent global genomic repair of benzo(a)pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 2000, 60:517-521.
32. Peterson L.A. Formation, repair and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines. J. Nucleic Acids 2010, Article ID # 284935, Available at http://www.sage-hindawi.com/journals/jna/2010/284935.html.
33. Abdel-Rahman S.Z., El-Zein R.A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett. 2000, 159:63-71.
34. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2003, 2:901-908.
35. Tuimala J., Szekely G., Gundy S., Hirvonen A., Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002, 23(6):1003-1008.
36. Hoffman G.R., Preston R.J. Genetic toxicology. Casarett & Doull's Essentials of Toxicology 2003, McGraw-Hill, New York. C.D. Klaassen, J.B. Watkins (Eds.).
37. Angelini S., Kumar R., Carbone F., Bermejo J.L., Maffei F., Cantelli-Forti G., Hemminki K., Hrelia P. Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity. Mutat. Res. 2008, 638(1-2):90-97.
38. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004, 25(5):757-763.
39. Marsin S., Vidal A.E., Sossou M., Ménissier-de Murcia J., Le Page F., Boiteux S., de Murcia G., Radicella J.P. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J. Biol. Chem. 2003, 278(45):44068-44074.
40. Collins A.R., Dusinská M., Horváthová E., Munro E., Savio M., Stetina R. Inter-individual differences in repair of DNA base oxidation. Measured in vitro with the comet assay. Mutagenesis 2001, 16(4):297-301.
41. Slyskova J., Dusinska M., Kuricova M., Soucek P., Vodickova L., Susova S., Naccarati A., Tulupova E., Vodicka P. Relationship between the capacity to repair 8-oxoguanine biomarkers of genotoxicity and individual susceptibility in styrene-exposed workers. Mutat. Res. 2007, 634:101-111.
42. Pachkowski B.F., Winkel S., Kubota Y., Swenberg J.A., Millikan R.C., Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiological data show interactions between codon 280 his and smoking. Cancer Res. 2006, 66(5):2860-2868.
43. Berquist B.R., Singh D.K., Fan J., Kim D., Gillenwater E., Kulkarni A., Bohr V.A., Ackerman E.J., Tomkinson A.E., Wilson D.M. Functional capacity of XRCC1 protein variants identified in DNA repair-deficient Chinese hamster ovary cell lines and the human population. Nucleic Acids Res. 2010, 38:5023-5035.
44. Zipprich J., Terry M.B., Brandt-Rauf P., Freyer G.A., Liao Y., Agrawal M., Gurvich I., Senie R., Santella R.M. XRCC1 polymorphisms and breast cancer risk from the New York site of the breast cancer family registry: a family-based case-control study. J. Carcinogen. 2010, 9(4):1-6.
45. Hao B., Miao X., Li Y., Zhang X., Sun T., Liang G., Zhao Y., Zhou Y., Wang H., Chen X., Zhang L., Tan W., Wei Q., Lin D., He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 2006, 25:3613-3620.
46. Liu L., Yuan P., Liu L., Wu C., Zhang X., Guo H., Zhong R., Xu Y., Wu J., Duan S., Rui R., Wu T., Nie S., Miao X., Lin D. A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res. Treat. 2010, June 13, 2010 (Epub ahead of print).
47. Mohamadynejad P., Saadat M. Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars Province, Southern Iran). Mol. Biol. Rep. 2007, September 14 (Epub ahead of print).
48. Kocabas N.A., Karahalil B. XRCC1 Arg399Gln genetic polymorphism in a Turkish population. Int. J. Toxicol. 2006, 25:419-422.
49. Sterpone S., Mastellone V., Padua L., Novelli F., Patrono C., Cornetta T., Giammarino D., Donato V., Testa A., Cozzi R. Single-nucleotide polymorphisms in BER and HRR genes. XRCC1 haplotypes and breast cancer risk in Caucasian women. J. Cancer Res. Clin. Oncol. 2010, 136:631-636.
50. Brem R., Cox D.G., Chapot B., Moullan N., Romestaing P., Gérard J.P., Pisani P., Hall J. The XRCC1 -77T>C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 2006, 27:2469-2474.
51. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and gylcophorin A variant frequency. Cancer Res. 1999, 59:2557-2561.
52. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., Mark J.E., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphism in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000, 21:965-971.
53. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., Vineis P. XRCC1, XRCC3, XPD gene polymorphisms. Smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001, 22(9):1437-1445.
54. Ji G., Gu A., Zhu P., Xia Y., Zhou Y., Hu F., Song L., Wang S., Wang X. Joint effects of XRCC1 polymorphisms and polycyclic aromatic hydrocarbons exposure on sperm DNA damage and male infertility. Toxicol. Sci. 2010, 116:92-98.
55. Binkova B., Chvatalova I., Lnienickova Z., Milcova A., Tulupova E., Farmer P.B., Sram R.J. PAH-DNA adducts in environmentally exposed populations in relation to metabolic and DNA repair gene polymorphisms. Mutat. Res. 2007, 620:49-61.
56. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., Munnia A., Matullo G., Peluso M. DNA adducts levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer 2001, 94:121-127.
57. Kuricova M., Naccarati A., Kumar R., Koskinen M., Sanyal S., Dusinska M., Tulinska J., Vodickova L., Liskova A., Jahnova E., Fuortes L., Haufroid V., Hemminki K., Vodicka P. DNA repair and cyclin D1 polymorphisms and styrene-induced genotoxicity and immunotoxicity. Toxicol. Appl. Pharmacol. 2005, 207:S302-S309.
58. Vodicka P., Kumar R., Stetina R., Musak L., Soucek P., Haufroid V., Sasiadek M., Vodickova L., Naccarati A., Sedikova J., Sanyal S., Kuricova M., Brsiak V., Norppa H., Buchancova J., Hemminki K. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ. Mol. Mutagen. 2004, 44:283-292.
59. Wang Q., Wang A.H., Tan H.S., Feng N.N., Ye Y.J., Feng X.Q., Liu G., Zheng Y.X., Xia Z.L. Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadiene. Carcinogenesis 2010, 31(May (5)):858-863.
60. Wang Q., Ji F., Sun Y., Qiu Y.L., Wang W., Wu F., Miao W.B., Li Y., Brandt-Rauf P.W., Xia Z.L. Genetic polymorphisms of XRCC1, HOGG1 and MGMT and micronucleus occurrence in Chinese vinyl chloride-exposed workers. Carcinogenesis 2010, 31:1068-1073.
61. Bolegenova N.K., Bekmanov B.O., Djansugurova L.B., Bersimbaev R.I., Salama S.A., Au W.W. Genetic polymorphisms and expression of minisatellite mutations in a 3 generation population around the Semipalatinsk nuclear explosion test site, Kazakhstan. Int. J. Hyg. Environ. Health 2009, 212:654-660.
62. Pastorelli R., Cerri A., Mezzetti M., Consonni E., Airoldi L. Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int. J. Cancer 2002, 100:9-13.
63. Shen J., Gammon M.D., Terry M.B., Wang L., Wang Q., Zhang F., Teitelbaum S.L., Eng S.M., Sagiv S.K., Gaudet M.M., Neugut A.I., Santella R.M. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2005, 14(2):336-342.
64. Matullo G., Guarrera S., Carturan S., Peluso M., Malaveille C., Davico L., Piazza A., Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer 2002, 92:562-567.
65. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomark. Prev. 2005, 14(7):1810-1818.
66. Sturgis E.M., Castillo E.J., Li L., Zheng R., Eicher A.S., Clayman G.L., Strom S.S., Spitz M.R., Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999, 20(11):2125-2129.
67. Lee J.M., Lee Y.C., Yang S.Y., Yan P.W., Luh S.P., Lee C.J., Chen C.J., Wu M.T. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer 2001, 95:240-246.
68. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L., Wang L., Wang X., Spitz M.R., Wei Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer 2000, 88:601-606.
69. Abdel-Rahman S.Z., Soliman A.S., Bondy M.L., Omar S., El-Badaway S.A., Khaled H.M., Seifeldin I.A., Levin B. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of the early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000, 159:79-86.
70. Wang C., Sun Y., Han R. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology 2008, (Epub ahead of print).
71. Tumer T.B., Yilmaz D., Tanrikut C., Sahin G., Ulusoy G., Arinç E. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk. Res. 2010, 34:1275-1281.
72. Gu A.H., Lian J., Lu N.X., Xia Y.K., Lu C.C., Song L., Wang S.H., Wang X.R. Association of XRCC1 gene polymorphisms with idiopathic azoospermia in a Chinese population. Asian J. Androl. 2007, 9(6):781-786.
73. Chen P.L., Yeh K.T., Tsai Y.Y., Koeh H., Liu Y.L., Lee H., Cheng Y.W. XRCC1, but not APE1 and hOGG1 gene polymorphisms is a risk factor for pterygium. Mol. Vis. 2010, 16:991-996.
74. Metsola K., Kataja V., Sillanpää P., Siivola P., Heikinheimo L., Eskelinen M., Kosma V.M., Uusitupa M., Hirvonen A. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res. 2005, 7(6):R987-R997.
75. Thyagarajan B., Anderson K.E., Folsom A.R., Jacobs D.R., Lynch C.F., Bargaje A., Khaliq W., Gross M.D. No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect. Prev. 2006, 30(4):313-321.
76. Patel A.V., Calle E.E., Pavluck A.L., Feigelson H.S., Thun M.J., Rodriguez C. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res. 2005, 7(6):R1168-R1173.
77. Silva S.N., Moita R., Azevedo A.P., Gouveia R., Manita I., Pina J.E., Rueff J., Gaspar J. Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect. Prev. 2007, 31(4):303-309.
78. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., Brinton L.A., Lissowska J., Bardin-Mikolajczak A., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomark. Prev. 2006, 15(2):353-358.
79. The Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from The Breast Cancer Association Consortium. J. Natl. Cancer Inst. 2006, 98(19):1382-1396.
80. Kim S.U., Park S.K., Yoo K.Y., Yoon K.S., Choi J.Y., Seo J.S., Park W.Y., Kim J.H., Noh D.Y., Ahn S.H., Choe K.J., Strickland P.T., Hirvonen A., Kang D. XRCC1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 2002, 12:335-338.
81. Li H., Ha T.C., Tai B.C. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta analysis. Breast 2009, 18:183-191.
82. Butkiewicz D., Rusin M., Enewold L., Shields P.G., Chorazy M., Harris C.C. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 2001, 22:593-597.
83. Ratnasinghe D., Yao S.X., Tangrea J.A., Qiao Y.L., Anderson M.R., Barrett M.J., Giffen C.A., Erozan Y., Tockman M.S., Taylor P.R. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2001, 10(2):119-123.
84. Lopez-Cima M.F., Gonzalez-Arriaga P., Garcia-Castro L., Pascual T., Marron M.G., Puente X.S., Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 2007, 7:162.
85. Zhang X., Miao X., Liang G., Hao B., Wang Y., Tan W., Li Y., Guo Y., He F., Wei F., Wei Q., Lin D. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res. 2005, 65(3):722-725.
86. Harms C., Salama S.A., Sierra-Torres C.H., Cajas-Salazar N., Au W.W. Polymorphisms in DNA repair genes, chromosome aberrations and lung cancer. Environ. Mol. Mutagen. 2004, 44:74-82.
87. David-Beabes G.L., London S.J. Genetic polymorphisms of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 2001, 34:333-339.
88. Hung R.J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaride D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Chabrier A., Borel S., Hall J., Boffetta P. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 2005, 97:56-76.
89. Divine K.K., Gilliland F.D., Crowell R.E., Stidley C.A., Bocklage T.J., Cook D.L., Belinsky S.A. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res. 2001, 273-278.
90. Park J.Y., Lee S.Y., Jeon H.S., Bae N.C., Chae S.C., Joo S., Kim C.H., Park J.H., Kam S., Kim S.I., Jung T.H. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomark. Prev. 2002, 11:23-27.
91. Zhou W., Liu G., Miller D.P., Thurston S.W., Xu L.L., Wain J.C., Lynch T.J., Su L., Christiani D.C. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2003, 12:359-365.
92. Kiyohara C., Takayama K., Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006, 54(3):267-283.
93. Schneider J., Classen V., Helmig S. XRCC1 polymorphism and lung cancer risk. Expert Rev. Mol. Diagn. 2008, 8:761-780.
94. Figueroa J.D., Malats N., Real F.X., Silverman D., Kogevinas M., Chanock S., Welch R., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Vinyals G.C., Rothman N., Garcia Clonas M. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet. 2007, 121:233-242.
95. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., Kiltie A.E. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet. 2007, 8:13.
96. Felini M.J., Oslhan A.F., Schroeder J.C., North K.E., Carozza S.E., Kelsey K.T., Liu M., Rice T., Wiencke J.K., Wrensch M.R. DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 2007, 29:55-58.
97. Huang W.Y., Gao Y.T., Rashid A., Sakoda L.C., Deng J., Shen M.C., Wany B.S., Han T.Q., Zhang B.H., Chen B.E., Rosenberg P.S., Chanock S.J., Hsing A.W. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 2008, 29(1):100-105.
98. Geng J., Zhang Y.W., Huang G.C., Chen L.B. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: a meta-analysis. World J. Gastroenterol. 2008, 14:6733-6737.
99. Stanczyk M., Sliwinski T., Cuchra M., Zubowska M., Bielecka-Kowalska A., Kowalski M., Szemraj J., Mlynarski W., Majsterek I. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol. Biol. Rep. 2010, April 4, 2010 (Epub ahead of print).
100. Xing D., Qi J., Miao X., Lu W., Tan W., Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int. J. Cancer 2002, 100:600-605.
101. Sobti R.C., Singh J., Kaur P., Pachouri S.S., Siddiqui E.A., Bindra H.S. XRCC1 codon 399 and ERCC1 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population. Cancer Genet. Cytogenet. 2007, 175:91-97.
102. Duell E.J., Holly E.A., Bracci P.M., Wiencke J.K., Kelsey K.T. A population-based study of the Arg399Gln polymorphism in X-ray cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002, 62:4630-4636.
103. Arizono K., Osada Y., Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. 2008, 38(3):186-191.
104. Misra R.R., Ratnasinghe D., Tangrea J.A., Virtamo J., Anderson M.R., Barrett M., Taylor P.R., Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003, 191:171-178.
105. Chen L., Ambrosone C.B., Lee J., Sellers T.A., Pow-Sang J., Park J.Y. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostrate cancer in White and Black Americans. J. Urol. 2006, 175(1):108-112.